Financing ·
Lifeward Ltd. entered into a securities purchase agreement with Oramed Pharmaceuticals Inc. and certain investors to…
LFWDLifeward Ltd.
Lifeward Ltd. entered into a securities purchase agreement with Oramed Pharmaceuticals Inc. and certain investors to issue $11,160,000 in senior secured convertible notes and accompanying warrants. The transaction consists of $5,580,000 in initial notes and warrants, which closed on July 6, 2026, and a second $5,580,000 tranche of notes and warrants contingent upon the company achieving a 150% increase in ReWalk unit sales or its stock price reaching $13.80 for ten consecutive trading days. The notes carry an 8.0% annual interest rate, increasing to 15.0% upon default, and feature an initial conversion price of $5.40 per share. The company also amended and restated existing notes and warrants to revise beneficial ownership and redemption provisions. Lifeward Ltd. is a medical technology company specializing in mobility solutions.